Labiana Health S.A. (LAB) — Strategic Asset Allocation Index

Latest as of December 2022: 266.5%

Labiana Health S.A. (LAB) has a Strategic Asset Allocation Index of 266.5% as of December 2022. Strategic assets (PP&E of €20.64 Million plus long-term investments of €-) total €20.64 Million, measured against net assets of €7.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

266.5%
Strategic Assets / Net Assets

Strategic Assets

€20.64 Million
PP&E + LT Investments

PP&E

€20.64 Million
EUR

Net Assets

€7.74 Million
EUR

Labiana Health S.A. Strategic Asset Allocation Index (2022–2022)

This chart shows how Labiana Health S.A.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the index stands at 266.5%, representing strategic assets of €20.64 Million against net assets of €7.74 Million EUR. Explore LAB operating cash flow to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Labiana Health S.A. (2022–2022)

The table below presents the year-by-year Strategic Asset Allocation Index for Labiana Health S.A. from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Labiana Health S.A. (LAB) market capitalisation.

Year SAAI Strategic Assets (EUR) PP&E LT Investments Net Assets Change (pp)
2022 266.5% €20.64 Million €20.64 Million €- €7.74 Million
pp = percentage points